The reformulated vaccine defends against new omicron strains, including XBB omicron variants. The panel stopped short of ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

Future COVID-19 vaccines and boosters should be bivalent – meaning they’ll target older strains of the virus as well as the newer omicron BA.4 and BA.5 variants – following a unanimous recommendation ...

U.S. health officials will present a new vaccine plan that recommends an annual COVID-19 booster and proposes changes to the ...

The COVID recommendation was part of documents the Food and Drug Administration released Monday that discuss simplifying and ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.

The vaccine advisory panel for the Food and Drug Administration (FDA) on Thursday voted to recommend matching the composition ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...